CD19 Polyclonal Antibody

Background:
CD19 is a B cell–specific molecule that controls B cell activation by complexing with the BCR. CD19 is a member of the Ig superfamily and is the dominant component for the signaling complex on B cells that includes CD21, CD81, and CD22.Humans with CD19 deficiency have reduced proliferative responses to BCR stimulation in vitro and mount impaired Ab responses to vaccination.

Research Area: Cancer, Immunology, Stem Cells

Synonyms:
Antibody deficiency due to defect in CD19, included, AW495831, B lymphocyte antigen CD19, B lymphocyte surface antigen B4, B-lymphocyte antigen CD19, B-lymphocyte surface antigen B4, B4, CD19, CD19 antigen, CD19 molecule, Cd19 protein, CD19, CVID3, Differentiation antigen CD19, Leu 12, Leu-12, Leu12, MGC109570, MGC12802, T-cell surface antigen Leu-12

Immunogen: KLH conjugated Synthetic peptide corresponding to Mouse CD19

Swissprot: P15391,P25918

Purification Method: Affinity purification

Buffer: PBS with 0.02% sodium azide, 1% BSA and 50% glycerol, pH7.4

Concentration: 0.54 mg/mL
Dilution: IHC 1:100-1:500, IF 1:100-1:500

Storage:
Store at -20°C. Avoid freeze / thaw cycles.